China court speeds up drug-patent disputes, clarifies rules before generic launch
By MLex Staff ( November 12, 2026, 08:54 GMT | Insight) -- China has sped up court proceedings and clarified rules for resolving drug-patent disputes before generic medicines reach the market, giving drugmakers clearer guidance on protecting innovation and pursuing market entry.China has sped up court proceedings and clarified rules for resolving drug-patent disputes before generic medicines reach the market, giving drugmakers clearer guidance on protecting innovation and pursuing market entry....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.